U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817160) titled 'Pelvic Floor Dysfunction in Pulmonary Systemic Sclerosis' on Aug. 26.
Brief Summary: Systemic sclerosis (SSc) is a heterogeneous multisystem disease characterized by vascular dysfunction, immune abnormalities, and progressive fibrosis of the skin and internal organs. Pulmonary involvement, particularly interstitial lung disease (ILD), is one of the most common and clinically important manifestations of SSc and may lead to impaired pulmonary function, respiratory muscle weakness, reduced diaphragmatic function, and decreased exercise capacity. In addition to pulmonary involvement, systemic inflammation, physical inactivity, nutritio...